CorpDev.Org
Daily News for Dealmakers
Big Deal
Home Depot’s $5.5 Billion GMS Acquisition: Strategic Masterstroke in Pro Market Expansion
Home Depot's acquisition of GMS Inc. for $5.5 billion represents a transformative consolidation in the building products distribution sector, accelerating its penetration into the professional contractor market through subsidiary SRS Distribution....
Metro Bank’s Majority Shareholder Explores Stake Sale Amid Private Equity Interest
Colombian billionaire Jaime Gilinski Bacal, Metro Bank's controlling shareholder with a 52.87% stake, is actively exploring a sale of his position following unsolicited investor interest and a sustained share price recovery. This development comes...
Shell Denies BP Mega-Merger: Strategic Implications for the Energy Sector
Shell's swift denial of merger talks with BP marks a pivotal moment in energy sector consolidation, revealing deeper strategic realignments as oil giants navigate volatile markets. The proposed $80 billion acquisition would have created a $300...
Record M&A Insurance Payouts Signal Fundamental Shift in Transaction Risk Management
Aon's landmark Global Transaction Solutions Claims Study reveals unprecedented activity in representations and warranties (R&W) insurance, with North American clients recovering a record $300 million in paid claims during 2024 alone—the highest...
Carlyle’s Strategic Positioning in Europe’s $16 Trillion Defense Transformation
As Europe undergoes its largest military buildup since the Cold War, The Carlyle Group is strategically positioning itself to capitalize on unprecedented public-private defense partnerships. The European Union's €800 billion "ReArm Europe"...
Top Jobs Currently Hiring
Thought Leadership
Private Equity
International
Tech, Media & Telecom
Financial Services
Health & Life Sciences
Hims & Hers’ Strategic Expansion into Canada: Leveraging ZAVA Acquisition and Generic Semaglutide for Market Disruption
Hims & Hers Health's planned 2026 Canadian expansion represents a pivotal strategic shift, combining its recent acquisition of European digital health platform ZAVA with the anticipated launch of generic semaglutide to target Canada's substantial...
Merck’s $10 Billion Verona Pharma Acquisition: Strategic Masterstroke in the COPD Therapeutics Revolution
The pharmaceutical industry witnessed a landmark transaction on July 9, 2025, as Merck & Co. announced its definitive agreement to acquire Verona Pharma for approximately $10 billion, securing rights to the breakthrough COPD therapy Ohtuvayre...
Torrent Pharma’s $1.4B JB Pharma Acquisition: KKR Exit Catalyzes CDMO Power Play
In a landmark transaction reshaping India's pharmaceutical landscape, Torrent Pharmaceuticals announced the acquisition of KKR's 46.39% controlling stake in JB Chemicals & Pharmaceuticals for ₹11,917 crore ($1.4 billion), with the full equity...
Danone’s Strategic Acquisition of The Akkermansia Company: Accelerating Leadership in Next-Generation Biotics
Danone has significantly advanced its gut health research capabilities through the acquisition of The Akkermansia Company, a pioneer in next-generation probiotics and postbiotics. This strategic move enhances Danone's scientific portfolio with...
ProAssurance Stockholders Overwhelmingly Approve $1.3 Billion Acquisition by The Doctors Company
ProAssurance Corporation (NYSE: PRA) shareholders have delivered a decisive mandate for the company's acquisition by The Doctors Company, with over 99% of voting shares endorsing the $1.3 billion transaction that will create the nation's largest...
Consumer and Industrial
